Edition:
United Kingdom

Tamara Mathias

Emergency allergy shots less effective after heat exposure

11 Dec 2018

(Reuters Health) - - The medicine in emergency allergy shots like the EpiPen can deteriorate when exposed to heat, so don't leave them in the car on a hot day, researchers warn.

Shares of Tivity Health drop 30 percent on Nutrisystem deal skepticism

10 Dec 2018

Shares of Tivity Health Inc plummeted over 30 percent on Monday after the company's deal to buy diet plan developer Nutrisystem Inc in a bid to strike new partnerships with large health insurers was met with skepticism.

Akorn CEO to retire after drugmaker fails to salvage Fresenius merger deal

07 Dec 2018

WILMINGTON, Del Akorn Inc said late on Friday its Chief Executive Officer would retire following the drugmaker's inability to salvage its takeover deal with Germany's Fresenius SE .

Mallinckrodt to spin off generics business, but to keep options open

06 Dec 2018

Mallinckrodt Plc plans to spin off its specialty generics business to shareholders by the second half of 2019, but said it was still open to a sale of the unit.

U.S. doctors asked how they feel about caring for transgender patients

03 Dec 2018

(Reuters Health) - Most primary care physicians in the U.S. are willing to provide routine care to transgender individuals, but that doesn't mean they are well prepared to do so, a small study suggests.

Yoga, acupuncture might ease menopause hot flashes

30 Nov 2018

- Acupuncture and yoga could offer relief from the hot flashes of menopause, a new analysis suggests.

FDA picks eight medical device firms to help battle opioid crisis

30 Nov 2018

Eight medical device makers, including a startup that uses virtual reality to treat chronic pain, topped an innovation contest aimed at addressing the opioid crisis, the U.S. Food and Drug Administration said on Friday.

Astellas Pharma gets U.S. nod for blood cancer treatment

28 Nov 2018

The U.S. Food and Drug Administration on Wednesday approved a blood cancer treatment from Japan's Astellas Pharma Inc, making it the first targeted therapy to treat patients with a certain mutation.

UPDATE 2-Astellas Pharma gets U.S. nod for blood cancer treatment

28 Nov 2018

Nov 28 The U.S. Food and Drug Administration on Wednesday approved a blood cancer treatment from Japan's Astellas Pharma Inc, making it the first targeted therapy to treat patients with a certain mutation.

Hygiene standards not up to the mark at farmers' markets

16 Nov 2018

(Reuters Health) - Vendors at farmers' markets could benefit from lessons in food-safety, according to researchers at Pennsylvania State University.

World News